Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Evolus Inc (EOLS)

Evolus Inc (EOLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evolus Inc 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 USA

P: 949-284-4555

Description:

Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California.

Key Statistics

Overview:

Market Capitalization, $K 444,833
Enterprise Value, $K 369,793
Shares Outstanding, K 56,095
Annual Sales, $ 99,670 K
Annual Net Income, $ -46,810 K
Last Quarter Sales, $ 37,160 K
Last Quarter Net Income, $ -23,470 K
60-Month Beta 2.01
% of Insider Shareholders 7.30%
% of Institutional Shareholders 50.60%
Float, K 52,000
% Float 92.70%
Short Volume Ratio 0.72

Growth:

1-Year Return 5.94%
3-Year Return -46.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 08/02/22
Next Earnings Date 11/01/22
Earnings Per Share ttm -1.41
EPS Growth vs. Prev Qtr -35.48%
EPS Growth vs. Prev Year -35.48%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

EOLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.14%
Return-on-Assets % -34.76%
Profit Margin % -46.97
Net Margin % N/A
Debt/Equity 1.06
Price/Sales 4.54
Price/Cash Flow N/A
Price/Book 9.66
Book Value/Share 0.84
Interest Coverage -32.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar